variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
APOE-C130R,APOE,"This is generally known as the ApoE4 allele of ApoE and is associated with increased risk of Alzheimer's. 20-25% of individuals are heterozygous for this variant, and 1-2% are homozygous. Data from Khachaturian et al. suggests an average 7% of all individuals developed Alzheimer's by the age of 80; when this is split by ApoE4 status: 10% of ApoE4 heterozygotes (3% increased attributable risk), 40% of ApoE4 homozygotes (33% increased attributable risk), and 5% of non-carriers (2% decreased attributable risk). Notably, their model suggests 70-75% of people would eventually develop Alzheimer's by the age of 100 regardless of ApoE4 genotype (and 25-30% are resistant, regardless of genotype), but that ApoE4 variants shift the disease onset to occur significantly earlier (4 years earlier for heterozygous carriers, 13 years for homozygotes).",High,Well-established,Pathogenic,0.14,Mental and behavioral;Nervous system,Complex/Other,Heterozygous,9343467;11950276;15123497;17428983,rs429358,4,chr19,45411941,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
PRODH-L441P,PRODH,"Causes hyperprolinemia in a recessive manner (high levels of proline in the blood due to a defect in metabolism of this amino acid). This can sometimes lead to seizures, mental retardation, and other neurological manifestations. Some authors also hypothesize hyperprolinemia is a risk factor for schizophrenia, but this is less well supported and the effect of this variant on risk for that disease is unclear.",High,Well-established,Pathogenic,0.0059,Blood;Mental and behavioral;Metabolism;Nervous system,Recessive,Heterozygous,12217952;15662599,rs2904551,5,chr22,18905934,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
MATN3-T303M,MATN3,"An Iceland study implicated this in causing increased osteoarthritis -- in particular, hand osteoarthritis. Because the variant is rare, the statistical significance of observations is weak. The authors estimate that individuals heterozygous for this variant have a 2.1-fold risk for hand osteoarthritis.",Moderate,Uncertain,Pathogenic,0.011,"Muscular, skeletal, and connective tissue",Unknown,Heterozygous,12736871,rs77245812,3,chr2,20202930,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
RPGRIP1L-A229T,RPGRIP1L,"This variant is generally not considered pathogenic, but when combined with other severe variants it is associated with rare genetic diseases which involve retinal degeneration. Carrying this variant increases the risk of these diseases, but the overall increased risk is very small because the diseases are very rare.",Low,Likely,Pathogenic,0.056,Hearing and vision,Unknown,Heterozygous,19430481,rs61747071,0,chr16,53720436,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
KRT5-G138E,KRT5,"This variant is associated with 1.25x increased risk of basal cell carcinoma (common skin cancer, rarely malignant).",Low,Likely,Pathogenic,0.052,Cancer;Skin,Unknown,Heterozygous,19578363,rs11170164,3,chr12,52913668,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
AMPD1-Q12X,AMPD1,"Causes Adenosine Deaminase Deficiency in a recessive manner. Most of the time individuals do not report symptoms, but when symptoms do exist they to be post-exercise symptoms of muscle weakness, muscle pain, and getting tired more quickly.",Low,Likely,Pathogenic,0.093,"Metabolism;Muscular, skeletal, and connective tissue",Recessive,Heterozygous,1631143,rs17602729,4,chr1,115236057,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Heterozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
NOD2-G908R,NOD2,"This variant is associated with an increased susceptibility to Crohn's disease and other inflammatory bowel diseases (IBD). Assuming an overall prevalence of 0.5% for IBD, this variant implies an increased attributable risk of 2% (5x increased risk, for an overall risk of 2.5% of IBD for people with this variant).",Low,Likely,Pathogenic,0.011,"Mouth, liver, and digestive",Unknown,Heterozygous,11385576;12019468,,2,chr16,50756540,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Homozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
TGFB1-R25P,TGFB1,"This variant in a growth factor gene is associated with variation in TGFB1 levels; this has been associated with various pathogenic and some protective effects, including: more hepatic fibrosis progression in hep C patients, lower risk of cleft palate, anticorrelation with longevity, higher risk of myocardial infarction and lower risk of hypertension.",Low,Uncertain,Pathogenic,0.049,Anatomical and congenital;Heart and circulatory,Complex/Other,Heterozygous,8901839;14596813;15212689;15569360,rs1800471,2,chr19,41858876,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
RNASEL-R462Q,RNASEL,"Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.",Low,Uncertain,Pathogenic,0.28,Cancer;Genital and urinary,Complex/Other,Heterozygous,11941539;12022038;12415269;17407163,rs486907,2,chr1,182554557,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
POLG-Q1236H,POLG,"Generally a nonpathogenic polymorphism, but may have a modifier effect that increases severity when combined in cis with other pathogenic variants.",Low,Uncertain,Pathogenic,0.058,Other,Complex/Other,Heterozygous,15917273;16595552,rs3087374,0,chr15,89859994,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
DYX1C1-E417X,DYX1C1,"One study reports this variant to be associated with dyslexia. The study group was relatively small and so the results did not have strong significance. If they are representative this variant is associated with a doubled risk for dyslexia, but it is unclear whether the effect would be additive, dominant, or recessive.",Low,Uncertain,Pathogenic,0.2,Mental and behavioral,Unknown,Homozygous,12954984,rs57809907,3,chr15,55722882,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
BRCA2-N372H,BRCA2,"This is a common variant of BRCA2 (HapMap allele frequency of 23%). The variant is weakly associated with an increased chance of breast cancer, and zygosity of the variant is associated with sex of children: male children are more likely to be homozygous for this variant, female children are more likely to be heterozygous.",Low,Uncertain,Pathogenic,0.24,Cancer,Recessive,Heterozygous,11062481;15235023,rs144848,2,chr13,32906729,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
DPYD-M166V,DPYD,Associated with DPYD deficiency and poor prognosis for chemotherapy w/ 5-flurorouracil. ,High,Likely,Pharmacogenetic,0.078,Other,Unknown,Heterozygous,11895907;14635116;19104657,rs2297595,5,chr1,98165091,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Heterozygous,,rs1544410,0,,,,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
ABCC6-R1268Q,ABCC6,This common polymorphism appears to not have a significant phenotypic impact. A few studies report weak but significant associations with plasma lipids (in Inuits) and thalidomide toxicity.,Low,Uncertain,Pharmacogenetic,0.22,Metabolism,Unknown,Heterozygous,10811882;10913334;11776382;20038957,rs2238472,1,chr16,16251599,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Homozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Homozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Homozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
IL7R-T244I,IL7R,"The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a ""protective"" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).",Low,Likely,Protective,0.21,Immune system;Nervous system,Unknown,Homozygous,12825072;17660530;17660816;17660817;21161391,rs6897932,0,chr5,35874575,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
TYR-R402Q,TYR,"This is a frequent pigmentation polymorphism in Europeans that affects function of the Tyrosinase gene. It is associated with blue instead of green eyes and sun sensitivity. For the most part this variant is benign, but many individuals with ocular albinism (which affects only the eyes) carry this variant along with another more severe variant in the same gene.",Low,Well-established,Benign,0.2,Hearing and vision,Complex/Other,Heterozygous,1820207;7704033;11284711;18326704;18488027;18488028;19533789,rs1126809,0,chr11,89017961,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Homozygous,,rs12742169,,chr1,201052310,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
OCA2-R419Q,OCA2,"This variant is associated with eye color, as is OCA2 R305W. Individuals with this variant are reported to be more likely to have green/hazel eyes as opposed to blue/gray eyes. Other variants in this gene are associated with oculocutaneous albinism (albinism which involves skin and eyes).",Low,Likely,Benign,0.057,Hearing and vision;Skin,Unknown,Heterozygous,12163334,rs1800407,,chr15,28230318,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Homozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
USH2A-V230M,USH2A,"This rare variant may be associated with Usher Syndrome II, but the literature seems to have concluded that it is a non-pathogenic polymorphism (including authors who earlier reported it as pathogenic).",Low,Uncertain,Benign,0.016,Hearing and vision,Recessive,Heterozygous,10909849;11311042;15325563;18273898,rs45500891,,chr1,216538391,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
UNC13D-A59T,UNC13D,"Probably benign. This variant was reported to cause haemophagocytic lymphohistiocytosis in a recessive manner, but its allele frequency is inconsistent with this hypothesis and so we evaluate it as a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.017,Blood,Unknown,Heterozygous,16825436,rs9904366,,chr17,73839326,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
GFAP-D295N,GFAP,Reported as a nonpathogenic polymorphism.,Low,Uncertain,Benign,0.033,Other,Unknown,Heterozygous,12175861,rs1126642,,chr17,42989063,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
DSP-R1537C,DSP,Probably benign / nonpathogenic.,Low,Uncertain,Benign,0.01,Other,Unknown,Heterozygous,20152563,rs28763967,,chr6,7581032,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Heterozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
AMPD1-P48L,AMPD1,"Probably benign, ancestral to15173240 pathogenic Q12X mutation.",Low,Uncertain,Benign,0.094,Other,Unknown,Heterozygous,15173240,rs61752479,,chr1,115231254,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Homozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
MAPT-R370W,MAPT,Probably benign.,Low,Uncertain,Benign,0.16,Other,Unknown,Heterozygous,15365985,rs17651549,,chr17,44061278,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Homozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
SPTA1-A970D,SPTA1,"This variant, also called alpha-IIa, has been seen frequently in individuals with recessive Hereditary spherocytosis. This appears to be the result of linkage to alpha-LEPRA (a C>T substitution at position -99 of intron 30); A970D is later reported as functionally neutral.",Low,Uncertain,Benign,0.037,Blood,Unknown,Heterozygous,8844207;9067503;15384986;16150946,rs35948326,,chr1,158624528,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Homozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
PHYH-P29S,PHYH,"Probably benign. This variant was implicated as causing Refsum Disease in a recessive manner, but a subsequent publication noted that all instances were linked with other explanatory mutations. The high allele frequency of this variant in the population (7-13%) contradicts a pathogenic hypothesis.",Low,Uncertain,Benign,0.16,Nervous system,Unknown,Heterozygous,10767344;14974078,rs28938169,0,chr10,13340236,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
NOTCH3-V1952M,NOTCH3,Probably benign.,Low,Uncertain,Benign,0.0078,Other,Unknown,Heterozygous,,rs115582213,,chr19,15273335,T,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Homozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
TPCN2-G734E,TPCN2,Pigmentation allele.,Low,Uncertain,Benign,0.29,Other,Unknown,Heterozygous,18488028,rs3829241,,chr11,68855363,A,http://evidence.personalgenomes.org/genomes?display_genome_id=3684b911e84d9287a84ac63ed6b7fa92cb546975&access_token=e63a40e5b6538993bc7e058093b6de45
